Evidence map›Paper›PMID 42477312›Full record

ArticleTranslational psychiatry2026

Antidepressant-like effects of ketamine involve CX

Yong-Yu Yin, Si-Rui Sun, Hui-Ying Zhang, Peng-Wei Bi, Jia-Ning Zhao, Hao Cheng, Yun-Feng Li

Abstract read
In one paragraph

Article in Translational psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yong-Yu Yin *Academy of Military Medical Sciences, Beijing, China. yongyuyin@qq.com.ORCID http://orcid.org/0000-0003-3045-5543
Si-Rui Sun *Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Hui-Ying ZhangShenyang Pharmaceutical University, Shenyang, China.
Peng-Wei BiGraduate Collaborative Training Base of Academy of Military Medical Sciences, Hengyang Medical School, University of South China, Hengyang, China.
Jia-Ning ZhaoShenyang Pharmaceutical University, Shenyang, China.
Hao ChengBeijing Ditan Hospital, Capital Medical University, Beijing, China. chenghaocn@yahoo.com.
Yun-Feng LiAcademy of Military Medical Sciences, Beijing, China. lyf619@aliyun.com.ORCID http://orcid.org/0000-0002-9696-890X

Funding

National Natural Science Foundation of China (National Science Foundation of China) 82304462
6 · The paper itself

Abstract

Ketamine, a non-competitive N-methyl-D-aspartate acid (NMDA) receptor antagonist, produces rapid and sustained antidepressant actions, but the underlying molecular mechanism remains unclear. The CX

Indexed as

Antidepressive AgentsChemokine CX3CL1CX3C Chemokine Receptor 1DepressionKetamineNeuronal PlasticityPrefrontal CortexAnimalsCorticosteroneMaleMiceMice, Inbred C57BLSignal TransductionAntidepressive AgentsChemokine CX3CL1CorticosteroneCX3C Chemokine Receptor 1Cx3cl1 protein, mouseCx3cr1 protein, mouseKetamine

Identifiers

PMID42477312
PMCPMC13662205

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.